(Q36252083)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

Bringing ayahuasca to the clinical research laboratory (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Manel J Barbanoj

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychoactive Drugs

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

219-230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16149336%20AND%20SRC:MED&resulttype=core&format=json

Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Inhibition by β-carbolines of monoamine uptake into a synaptosomal preparation: Structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Pharmacokinetics of Hoasca alkaloids in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Comparison of simultaneously recorded [H2(15)O]-PET and LORETA during cognitive and pharmacological activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

On the relationship of synaptic activity to macroscopic measurements: does co-registration of EEG with fMRI make sense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Psychometric assessment of the Hallucinogen Rating Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Dimethyltryptamin: its metabolism in man; the relation to its psychotic effect to the serotonin metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804

Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399804